Uría and Cuatrecasas instructed by Progenika Biopharma on Grifols deal

Uría Menéndez and Cuatrecasas Gonçalves Pereira advised Spain’s Progenika Biopharma on the sale of a 33 per cent stake in the company to Grifols.


Grifols was advised by Osborne Clarke in relation to the transaction.

The deal was valued at €25 million, according to Mergermarket.

Grifols reported net revenues of €3.9 billion in 2015.

Ben Cook